クローン病治療の世界市場（2025年）

世界のクローン病治療の市場規模は、今後数年間で力強い成長が見込まれており、2029年に176億7,000万米ドルに達すると予測され、CAGRで7.5%の成長が見込まれます。予測期間の成長は、個別化医療へのアプローチ、生物製剤市場の拡大、治療ガイドラインの進化、医療費の増加、共同研究活動に起因すると考えられます。予測期間の主要動向は、患者管理に向けた遠隔医療、免疫調節戦略の研究、患者中心のケアモデル、デジタルヘルスソリューションの統合などです。

炎症性腸疾患の有病率の上昇がクローン病治療市場の成長を促進すると予測されます。炎症性腸疾患には、消化管の炎症を特徴とする慢性疾患群が含まれ、口から肛門までの消化器系のあらゆる部分に影響を及ぼす可能性があります。クローン病の治療は、腸の炎症を抑え、症状の急性増悪を防ぎ、寛解を維持することを目的としています。例えば2023年9月、National Center for Biotechnology Informationは、クローン病と潰瘍性大腸炎の有病率の上昇を報告しており、炎症性腸疾患は2023年に人口10万人当たり825人（クローン病は410人、潰瘍性大腸炎とIBDUは414人）と推定されています。その結果、これらの疾患の増加傾向がクローン病治療市場の成長に寄与しています。

高齢化の進行はクローン病治療市場の拡大を促進すると予測されます。高齢者の割合の増加を特徴とするこの人口動態の変化は、クローン病を含む慢性疾患の有病率の上昇に寄与し、それによって治療に対する需要が高まります。例えば、米国の非営利団体であるPopulation Reference Bureau（PRB）は2024年1月、65歳以上の米国人の数が2022年の5,800万人から2050年までに8,200万人へと47%増加すると予測しています。この年齢層が人口に占める割合は17%から23%に増加すると予測されています。このように、高齢化の拡大がクローン病治療市場を後押ししています。

当レポートでは、世界のクローン病治療市場について調査分析し、市場の特徴、市場の動向と戦略、各地域の分析、競合情勢などの情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 クローン病治療市場の特徴

第3章 クローン病治療市場の動向と戦略

第4章 クローン病治療市場 - 市場に対する金利、インフレ、地政学、COVIDと回復の影響を含むマクロ経済シナリオ

第5章 世界のクローン病治療の成長分析、戦略的分析フレームワーク

• 世界のクローン病治療のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のクローン病治療市場の成長率の分析
• 世界のクローン病治療の市場規模と成長の実績（2019年～2024年）
• 世界のクローン病治療の市場規模と成長の予測（2024年～2029年・2034年）
• 世界のクローン病治療の総市場規模（TAM）

第6章 クローン病治療市場のセグメンテーション

• 世界のクローン病治療市場：薬剤タイプ別、実績と予測（2019年～2024年・2024年～2029年・2034年）
• 抗生物質
• アミノサリチル酸
• コルチコステロイド
• 免疫調節薬
• その他の薬剤タイプ
• 世界のクローン病治療市場：流通チャネル別、実績と予測（2019年～2024年・2024年～2029年・2034年）
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のクローン病治療市場：用途別、実績と予測（2019年～2024年・2024年～2029年・2034年）
• 神経障害性疼痛
• 線維筋痛症
• 慢性腰痛
• 関節炎痛
• 片頭痛術後疼痛
• がん疼痛
• その他の用途
• 世界のクローン病治療市場、抗生物質のサブセグメンテーション：タイプ別、実績と予測（2019年～2024年・2024年～2029年・2034年）
• メトロニダゾール
• シプロフロキサシン
• その他の抗生物質
• 世界のクローン病治療市場、アミノサリチル酸塩のサブセグメンテーション：タイプ別、実績と予測（2019年～2024年・2024年～2029年・2034年）
• メサラミン
• スルファサラジン
• その他のアミノサリチル酸塩
• 世界のクローン病治療市場、コルチコステロイドのサブセグメンテーション：タイプ別、実績と予測（2019年～2024年・2024年～2029年・2034年）
• プレドニゾン
• ブデソニド
• その他のコルチコステロイド
• 世界のクローン病治療市場、免疫調節剤のサブセグメンテーション：タイプ別、実績と予測（2019年～2024年・2024年～2029年・2034年）
• アザチオプリン
• メトトレキサート
• メルカプトプリン
• 世界のクローン病治療市場、その他の薬剤タイプのサブセグメンテーション：タイプ別、実績と予測（2019年～2024年・2024年～2029年・2034年）
• 生物学的製剤
• 低分子
• その他の治療

第7章 クローン病治療市場の地域と国の分析

• 世界のクローン病治療市場：地域別、実績と予測（2019年～2024年・2024年～2029年・2034年）
• 世界のクローン病治療市場：国別、実績と予測（2019年～2024年・2024年～2029年・2034年）

第8章 アジア太平洋のクローン病治療市場

第9章 中国のクローン病治療市場

第10章 インドのクローン病治療市場

第11章 日本のクローン病治療市場

第12章 オーストラリアのクローン病治療市場

第13章 インドネシアのクローン病治療市場

第14章 韓国のクローン病治療市場

第15章 西欧のクローン病治療市場

第16章 英国のクローン病治療市場

第17章 ドイツのクローン病治療市場

第18章 フランスのクローン病治療市場

第19章 イタリアのクローン病治療市場

第20章 スペインのクローン病治療市場

第21章 東欧のクローン病治療市場

第22章 ロシアのクローン病治療市場

第23章 北米のクローン病治療市場

第24章 米国のクローン病治療市場

第25章 カナダのクローン病治療市場

第26章 南米のクローン病治療市場

第27章 ブラジルのクローン病治療市場

第28章 中東のクローン病治療市場

第29章 アフリカのクローン病治療市場

第30章 クローン病治療市場の競合情勢と企業プロファイル

• クローン病治療市場の競合情勢
• クローン病治療市場の企業プロファイル
  • AbbVie Inc.
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • Eli Lilly and Company
  • Janssen Pharmaceuticals

第31章 クローン病治療市場のその他の主要企業と革新的企業

• Pfizer Inc.
• Takeda Pharmaceutical Company Limited
• Biogen Inc.
• Bristol-Myers Squibb Company
• Galapagos NV
• Novartis AG
• Sanofi S.A.
• F. Hoffmann-La Roche Ltd.
• Teva Pharmaceutical Industries Ltd.
• Merck & Co. Inc.
• Mylan N.V.
• Glenmark Pharmaceuticals
• Tillotts Pharma AG
• Dr. Falk Pharma GmbH
• Shire Pharmaceuticals

第32章 世界のクローン病治療市場の競合ベンチマーキングとダッシュボード

第33章 クローン病治療市場における主な合併と買収

第34章 クローン病治療市場の近年の発展

第35章 クローン病治療市場の潜在性の高い国、セグメント、戦略

• クローン病治療市場 - もっとも新しい機会を提供する国（2029年）
• クローン病治療市場 - もっとも新しい機会を提供するセグメント（2029年）
• クローン病治療市場 - 成長戦略（2029年）
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Crohn's disease treatment encompasses medical interventions and therapies designed to manage Crohn's disease, a chronic gastrointestinal condition. The primary goals of treatment are to mitigate inflammation in the intestines, prevent symptom flare-ups, and sustain overall recovery.

The key drug categories in Crohn's disease treatment include antibiotics, aminosalicylates, corticosteroids, immunomodulators, and others. Antibiotics are pharmaceuticals utilized for both treating and preventing bacterial infections. These drugs are accessible through diverse channels, including hospital pharmacies, retail pharmacies, and online pharmacies. They find applications in various medical conditions such as neuropathic pain, fibromyalgia, chronic back pain, arthritic pain, migraine, post-operative pain, cancer pain, and other therapeutic areas.

The Crohn's disease treatment market research report is one of a series of new reports from The Business Research Company that provides Crohn's disease treatment market statistics, including Crohn's disease treatment industry global market size, regional shares, competitors with a Crohn's disease treatment market share, detailed Crohn's disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the Crohn's disease treatment industry. This Crohn's disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The crohn's disease treatment market size has grown strongly in recent years. It will grow from$12.45 billion in 2024 to $13.23 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increased disease prevalence, advancements in diagnostic techniques, biological therapies adoption, patient awareness and education, clinical research and development

The crohn's disease treatment market size is expected to see strong growth in the next few years. It will grow to $17.67 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to personalized medicine approaches, biologics market expansion, evolving treatment guidelines, increased healthcare spending, collaborative research efforts. Major trends in the forecast period include telemedicine for patient management, research on immune modulation strategies, patient-centric care models, integration of digital health solutions.

The rising prevalence of inflammatory bowel disorders is expected to drive growth in the Crohn's disease treatment market. Inflammatory bowel disorders include a group of chronic conditions characterized by inflammation in the gastrointestinal tract, which can affect any part of the digestive system, from the mouth to the anus. Treatments for Crohn's disease aim to reduce intestinal inflammation, prevent symptom flare-ups, and maintain remission. For example, in September 2023, the National Center for Biotechnology Information reported a rise in the prevalence of Crohn's disease and ulcerative colitis, with inflammatory bowel disease projected at 825 cases per 100,000 people in 2023-410 for Crohn's disease and 414 for ulcerative colitis and IBD-unclassified. Consequently, the increasing occurrence of these disorders is contributing to the growth of the Crohn's disease treatment market.

The growing aging population is anticipated to drive the expansion of the Crohn's disease treatment market. This demographic shift, characterized by an increasing proportion of elderly individuals, contributes to a higher prevalence of chronic conditions, including Crohn's disease, thereby raising the demand for treatments. For example, in January 2024, the Population Reference Bureau (PRB), a U.S.-based nonprofit, projected that the number of Americans aged 65 and older would increase from 58 million in 2022 to 82 million by 2050, a 47% rise. This age group's share of the population is expected to grow from 17% to 23%. Thus, the expanding aging population is boosting the Crohn's disease treatment market.

Leading companies in the Crohn's disease treatment market are advancing drug innovation and securing approvals, including for biosimilars like ustekinumab, to provide more effective and accessible treatment options that enhance patient outcomes and quality of life. Biosimilar ustekinumab is a biologic closely matching the original ustekinumab (a monoclonal antibody) used for autoimmune conditions. For instance, in July 2024, Switzerland-based Sandoz International GmbH launched Pyzchiva (ustekinumab) across Europe, making it the first ustekinumab biosimilar available in all strengths, including a 130 mg vial for Crohn's disease. This treatment is approved for adults and children over six with plaque psoriasis, psoriatic arthritis, and Crohn's disease, expanding Sandoz's immunology portfolio and enhancing access to affordable treatments for chronic inflammatory diseases.

Major companies in the Crohn's disease treatment market are directing efforts toward the development of new treatment options, including oral medications for moderate-severe Crohn's disease. In March 2022, AbbVie Inc. announced FDA approval for RINVOQ (upadacitinib), the first once-daily oral medication for patients with moderate-to-severe Crohn's disease. This selective Janus kinase (JAK) inhibitor precisely targets inflammation pathways, offering a potential reduction in adverse events linked to immunosuppression.

In March 2022, Pfizer Inc., a prominent US-based biopharmaceutical company, completed the acquisition of Arena Pharmaceuticals Inc. for approximately $6.7 billion. This strategic acquisition aimed to expand Pfizer's inflammation and immunology therapeutic area pipeline portfolio, encompassing conditions such as atopic dermatitis, eosinophilic esophagitis, ulcerative colitis, and Crohn's disease. Arena Pharmaceuticals Inc., a US-based biopharmaceutical company, significantly contributes to Pfizer's presence and offerings in the Crohn's disease treatment market.

Major companies operating in the crohn's disease treatment market include AbbVie Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceuticals, Pfizer Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Bristol-Myers Squibb Company, Galapagos NV, Novartis AG, Sanofi S.A., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Arena Pharmaceuticals Inc.

North America was the largest region in the global Crohn's disease treatment market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the crohn's disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the crohn's disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The crohn's disease treatment market consists of sales of vedolizumab, methotrexate, and infliximab. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Crohn's Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on crohn's disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for crohn's disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The crohn's disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Antibiotics; Amino Salicylates; Corticosteroids; Immunomodulators; Other Drug Types
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 3) By Application: Neuropathic Pain; Fibromyalgia; Chronic Back Pain; Arthritic Pain; Migraine Post-Operative Pain; Cancer Pain; Other Applications
• Subsegments:
• 1) By Antibiotics: Metronidazole; Ciprofloxacin; Other Antibiotics
• 2) By Amino Salicylates: Mesalamine; Sulfasalazine; Other Amino Salicylates
• 3) By Corticosteroids: Prednisone; Budesonide; Other Corticosteroids
• 4) By Immunomodulators: Azathioprine; Methotrexate; Mercaptopurine
• 5) By Other Drug Types: Biologics; Small Molecules; Other Treatments
• Companies Mentioned: AbbVie Inc.; AstraZeneca plc; Boehringer Ingelheim GmbH; Eli Lilly and Company; Janssen Pharmaceuticals
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Crohn's Disease Treatment Market Characteristics

3. Crohn's Disease Treatment Market Trends And Strategies

4. Crohn's Disease Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Crohn's Disease Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Crohn's Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Crohn's Disease Treatment Market Growth Rate Analysis
• 5.4. Global Crohn's Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Crohn's Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Crohn's Disease Treatment Total Addressable Market (TAM)

6. Crohn's Disease Treatment Market Segmentation

• 6.1. Global Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Amino Salicylates
• Corticosteroids
• Immunomodulators
• Other Drug Types
• 6.2. Global Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.3. Global Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neuropathic Pain
• Fibromyalgia
• Chronic Back Pain
• Arthritic Pain
• Migraine Post-Operative Pain
• Cancer Pain
• Other Applications
• 6.4. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metronidazole
• Ciprofloxacin
• Other Antibiotics
• 6.5. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Amino Salicylates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mesalamine
• Sulfasalazine
• Other Amino Salicylates
• 6.6. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prednisone
• Budesonide
• Other Corticosteroids
• 6.7. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Azathioprine
• Methotrexate
• Mercaptopurine
• 6.8. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biologics
• Small Molecules
• Other Treatments

7. Crohn's Disease Treatment Market Regional And Country Analysis

• 7.1. Global Crohn's Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Crohn's Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Crohn's Disease Treatment Market

• 8.1. Asia-Pacific Crohn's Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Crohn's Disease Treatment Market

• 9.1. China Crohn's Disease Treatment Market Overview
• 9.2. China Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Crohn's Disease Treatment Market

• 10.1. India Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Crohn's Disease Treatment Market

• 11.1. Japan Crohn's Disease Treatment Market Overview
• 11.2. Japan Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Crohn's Disease Treatment Market

• 12.1. Australia Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Crohn's Disease Treatment Market

• 13.1. Indonesia Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Crohn's Disease Treatment Market

• 14.1. South Korea Crohn's Disease Treatment Market Overview
• 14.2. South Korea Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Crohn's Disease Treatment Market

• 15.1. Western Europe Crohn's Disease Treatment Market Overview
• 15.2. Western Europe Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Crohn's Disease Treatment Market

• 16.1. UK Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Crohn's Disease Treatment Market

• 17.1. Germany Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Crohn's Disease Treatment Market

• 18.1. France Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Crohn's Disease Treatment Market

• 19.1. Italy Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Crohn's Disease Treatment Market

• 20.1. Spain Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Crohn's Disease Treatment Market

• 21.1. Eastern Europe Crohn's Disease Treatment Market Overview
• 21.2. Eastern Europe Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Crohn's Disease Treatment Market

• 22.1. Russia Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Crohn's Disease Treatment Market

• 23.1. North America Crohn's Disease Treatment Market Overview
• 23.2. North America Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Crohn's Disease Treatment Market

• 24.1. USA Crohn's Disease Treatment Market Overview
• 24.2. USA Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Crohn's Disease Treatment Market

• 25.1. Canada Crohn's Disease Treatment Market Overview
• 25.2. Canada Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Crohn's Disease Treatment Market

• 26.1. South America Crohn's Disease Treatment Market Overview
• 26.2. South America Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Crohn's Disease Treatment Market

• 27.1. Brazil Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Crohn's Disease Treatment Market

• 28.1. Middle East Crohn's Disease Treatment Market Overview
• 28.2. Middle East Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Crohn's Disease Treatment Market

• 29.1. Africa Crohn's Disease Treatment Market Overview
• 29.2. Africa Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Crohn's Disease Treatment Market Competitive Landscape And Company Profiles

• 30.1. Crohn's Disease Treatment Market Competitive Landscape
• 30.2. Crohn's Disease Treatment Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Janssen Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

31. Crohn's Disease Treatment Market Other Major And Innovative Companies

• 31.1. Pfizer Inc.
• 31.2. Takeda Pharmaceutical Company Limited
• 31.3. Biogen Inc.
• 31.4. Bristol-Myers Squibb Company
• 31.5. Galapagos NV
• 31.6. Novartis AG
• 31.7. Sanofi S.A.
• 31.8. F. Hoffmann-La Roche Ltd.
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. Merck & Co. Inc.
• 31.11. Mylan N.V.
• 31.12. Glenmark Pharmaceuticals
• 31.13. Tillotts Pharma AG
• 31.14. Dr. Falk Pharma GmbH
• 31.15. Shire Pharmaceuticals

32. Global Crohn's Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Crohn's Disease Treatment Market

34. Recent Developments In The Crohn's Disease Treatment Market

35. Crohn's Disease Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Crohn's Disease Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Crohn's Disease Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Crohn's Disease Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer